Delivering Pandemic Resilience

Supply Chain Resilience

With countries across the world pinning their hopes on the efficient rollout of lifesaving vaccines in the fight against COVID-19, Governments, NGOs, and medical-supplies companies are working at pace to ensure that their supply chain planning is resilient for this and future public health emergencies.

Bringing medical supplies from their distant sources for use at the frontline was one of the most crucial activities in pandemic response management during the first phase of the COVID-19 health emergency.

In our white paper ‘Delivering Pandemic Resilience’, we’ve worked with McKinsey & Company as analytics partner, on finding answers to some of the big supply chain questions for countries facing large-scale public health emergencies.

We’ve also identified the challenges faced and lessons learned in the wake of the first phase of the COVID-19 pandemic, and particularly around inbound logistics and distribution.

Our white paper talks about the scale of the challenge as people prepare to leap the next hurdles of COVID-19 vaccine logistics. For example, how can we store and ship vaccines at new extremes of temperature? What is the best way to organize the global supply chain to make sure vaccines arrive on time? And how can we cater to the needs of different geographical areas while ensuring sustainability in delivery and distribution?

Finally, we offer a framework for tackling future emergencies that cover robust emergency-response planning, the need for a strong partnership network, how to build the right logistics infrastructure, and how to ensure your IT gives you high-level visibility over critical success factors such as stock levels.  

Download our white paper and let’s start a conversation about how we can all work together – both public and private-sector organizations alike – so that our supply chains are fit enough to cope with whatever the next, big public-health emergency throws at us.